What is Areteia Therapeutics worth?
$1.3Blast known valuation
Areteia Therapeutics last raised $425.0M in its Early Stage VC (Series A1) (Feb 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Areteia Therapeutics
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2024 | Early Stage VC (Series A1) | $425.0M | ▮ | ▮ |
| Jun 2022 | Later Stage VC | $360.0M | ▮ | ▮ |
How Areteia Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Areteia Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Areteia Therapeutics worth?
- Areteia Therapeutics's last known valuation is $1.3B.
- How much has Areteia Therapeutics raised?
- Areteia Therapeutics has raised $425.0M in total funding across 2 recorded rounds.
- When did Areteia Therapeutics last raise?
- Areteia Therapeutics last raised in Feb 2024 (Early Stage VC (Series A1)), raising $425.0M.